Regeneron Pharmaceuticals (REGN)

Stock-Based Compensation

$986.70M

TTM · Period ending: · USD

REGN logo

REGN Stock-Based Compensation

Latest reported$986.70M
REGN TTM Stock-Based Comp ($0.00 → $986.70M)
High-resolution chart · PNG

REGN stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.